Last reviewed · How we verify
Metastatic thyroid carcinoma
Approved treatments
- Doxorubicin Hydrochloride · Pfizer Inc.
Doxorubicin intercalates nucleotide bases and interacts with topoisomerase II to form DNA-cleavable complexes, inhibiting DNA/RNA replication.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic thyroid carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic thyroid carcinoma treatment landscape brief
- Metastatic thyroid carcinoma treatment updates RSS
Frequently asked questions about Metastatic thyroid carcinoma
What drugs treat Metastatic thyroid carcinoma?
Tracked treatments include Doxorubicin Hydrochloride.
What is the treatment for Metastatic thyroid carcinoma?
Standard treatment for Metastatic thyroid carcinoma includes Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Metastatic thyroid carcinoma patent cliff · Metastatic thyroid carcinoma CI report
- Treatment: Doxorubicin Hydrochloride · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing